使用组合算法识别临床相关的T细胞受体,用于个性化T细胞治疗
Rémy Pétremand1,2, Johanna Chiffelle1,2, Sara Bobisse1,2
1Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
Nature biotechnology
|May 7, 2024
概括
识别瘤反应性T细胞受体 (TCRs) 是个性化癌症免疫治疗的关键. TRTpred是一种新的工具,使用转录学预测瘤反应性TCR,有助于开发有效的T细胞疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 生物信息学是一种生物信息学.
- 癌症研究 癌症研究
背景情况:
- 个性化癌症免疫疗法依赖于识别瘤向的T细胞受体 (TCRs).
- 从旁观者细胞区分瘤反应性T细胞是一个重大挑战.
研究的目的:
- 开发和验证一种抗原不可知计算工具TRTpred,用于预测瘤反应性T细胞受体 (TCRs).
- 将TRTpred与贪预测器集成,创建一个组合算法,用于为个性化的T细胞疗法选择临床相关的TCR.
主要方法:
- TRTpred是通过利用瘤反应性T细胞与旁观者T细胞的独特转录组概况来构建的.
- TRTpred 的业绩在 silico.com 中进行了基准评价.
- TRTpred与一个狂热度预测器集成,形成一个组合算法.
主要成果:
- TRTpred证明了作为瘤反应型TCRs的抗原不可知预测剂的有效性.
- 结合算法,集成TRTpred和一个狂热预测器,在患者衍生的异种移植中进行了基准测试.
结论:
- TRTpred代表了一种新的计算方法来识别瘤反应型TCRs.
- 开发的组合算法显示了为个性化癌症免疫治疗选择TCR的前景,需要进一步的临床验证.
相关概念视频
Diversity of Antigen Receptors
574
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
574
T Cell Activation and Clonal Selection
709
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
709
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518


